Welcome to our dedicated page for Foresight Autonomous Hldgs SEC filings (Ticker: FRSX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stereo vision algorithms, Israeli GAAP bridges, and multi-year patent tables can make Foresight Autonomous Holdings Ltd (FRSX) filings a challenge. Whether you are digging for R&D capitalization details or tracking sensor-fusion revenue milestones, the documents are dense. That’s why our page opens every Foresight Autonomous Holdings SEC filing with an AI-powered summary that translates technical language into clear insights. No more hunting through hundreds of pages to locate Foresight Autonomous Holdings insider trading Form 4 transactions or the latest dilution note.
Each form is linked the moment it hits EDGAR, and Stock Titan’s engine highlights what matters: cash burn trends in the Foresight Autonomous Holdings quarterly earnings report 10-Q filing, option grants inside the Foresight Autonomous Holdings proxy statement executive compensation, or collaboration news from a Foresight Autonomous Holdings 8-K material events explained. Our platform also delivers Foresight Autonomous Holdings Form 4 insider transactions real-time alerts, so you can see when executives act on their own shares. Use the “Ask AI” panel for understanding Foresight Autonomous Holdings SEC documents with AI; it answers natural questions like “How much was spent on sensor fusion R&D this quarter?”
Investors typically want quick context before committing hours to a deep read. Here’s how they use our coverage:
- Perform a Foresight Autonomous Holdings earnings report filing analysis to compare quarter-over-quarter revenue from pilot projects.
- Scan the Foresight Autonomous Holdings annual report 10-K simplified section to evaluate patent lifecycles and royalty streams.
- Monitor Foresight Autonomous Holdings executive stock transactions Form 4 ahead of product roadmap announcements.
All filings—10-K, 10-Q, 8-K, Form 4, S-8, F-3—are here, updated in real time and paired with concise AI commentary. With Foresight Autonomous Holdings SEC filings explained simply, you save hours and focus on decisions, not document mining.
Foresight Autonomous Holdings Ltd. filed a prospectus to register up to 3,179,723 American Depositary Shares (ADSs), representing 95,391,690 ordinary shares, for resale by selling shareholders upon exercise of Series A and Series C warrants. The company is not selling ADSs itself and will not receive proceeds from shareholders’ resale, but expects only nominal cash from Series A Warrants, which have a $0.02 per ADS exercise price, and approximately $2.8 million from full exercise of Series C Warrants at $2.7125 per ADS. As of December 7, 2025, 131,194,081 ordinary shares were outstanding, with potential additional dilution from warrants and equity plans. The filing highlights that investing in these ADSs is highly speculative, notes prior Nasdaq minimum bid-price non‑compliance that was subsequently cured, and references an earlier going‑concern explanatory paragraph in the company’s June 30, 2025 financial statements.
Foresight Autonomous Holdings Ltd. (FRSX) reports that it will hold its Annual General Meeting of Shareholders on December 29, 2025. A voting instruction form for holders of American Depositary Shares, to be sent by The Bank of New York Mellon, is attached to this report and forms part of the meeting materials.
Only shareholders of record who held Ordinary Shares or American Depositary Shares at the close of business on November 24, 2025 are entitled to vote at the meeting and at any postponement or adjournment. This report is also incorporated by reference into the company’s existing Form F-3 and Form S-8 registration statements.
Foresight Autonomous Holdings Ltd. (FRSX) filed a Form 6-K announcing its Annual General Meeting of Shareholders, scheduled for December 29, 2025. The meeting materials, including the notice, proxy statement and proxy card, are attached as an exhibit and incorporated by reference.
Shareholders of record holding ordinary shares or American Depositary Shares at the close of business on November 24, 2025 are entitled to vote at the meeting and any postponements or adjournments. This report is also incorporated by reference into several existing Form F-3 and Form S-8 registration statements, meaning those registration statements will automatically include the information provided in this submission.
Foresight Autonomous Holdings Ltd. (FRSX) submitted a Form 6-K announcing that its Eye-Net solution is entering a large-scale live public transportation safety trial in France together with Renault Group and Orange. The update is provided through a press release dated November 20, 2025, which is furnished as Exhibit 99.1.
The first five paragraphs and the forward-looking statements section of this press release are incorporated by reference into Foresight’s existing shelf registration statements on Form F-3 and equity compensation registrations on Form S-8, making the trial information and related forward-looking disclosures part of those offerings.
FAQ
What is the current stock price of Foresight Autonomous Hldgs (FRSX)?
What is the market cap of Foresight Autonomous Hldgs (FRSX)?
